LONDON--(BUSINESS WIRE)--The global selective serotonin reuptake inhibitors market is expected to post a CAGR of close to 4% during the period 2019-2023, according to the latest market research report ...
A large Australian study showed atypical depression has distinct genetic, clinical, and treatment-response features. Read ...
Centanafadine is a serotonin-norepinephrine-dopamine reuptake inhibitor. The two, 6-week, multicenter, double-blind, placebo-controlled trials (Study 1 and Study 2) evaluated the efficacy and safety ...
Most of the available anti-depressant drugs do one thing: They selectively block reuptake. That is why they are called selective reuptake inhibitors. A drug that is a selective serotonin reuptake ...
In the nervous system, electrical signals are sent down a nerve cell (neuron) to a synapse that transmit the electrical signal from one nerve cell to another. Their main purpose is to limit the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results